Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats

Abstract

This is the first study to demonstrate that administration of an opioid antagonist prevents the development of hepatic fibrosis in cirrhosis. Opioids can influence liver fibrogenesis directly via the effect on HSCs and regulation of the redox sensitive mechanisms in the liver.